Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Flu season is ramping up, and some experts are "pretty worried" - 2Figure out How to Pick a SUV with Senior-Accommodating Tech Elements
- 3The Difficulties of Getting a Green Card in the US
- 4Hamas delegation meets Egypt’s spy chief amid mutual ceasefire violation claims
- 5Figure out How to Ascertain the Restitution Time frame for Your Sunlight based chargers
- Examination In progress into Abuse of Japanese Government-Supported Advance
- The most effective method to Perceive the Early Side effects of Cellular breakdown in the lungs
- Could the Star of Bethlehem have actually been a comet?
- Merz postpones Norway trip for Belgium talks on frozen Russian assets
- 6 Exemplary Mexican Dishes
- Extreme Manual for Picking a Camper Van
- 5 Bike Brands for Ordinary Use
- Make Your Fantasy Closet: 10 Immortal Design Fundamentals
- How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker
